BARCLAYS PLC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 115 filers reported holding AKERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,188
+157.3%
339,846
+137.5%
0.01%
+175.0%
Q2 2023$6,680
+126.1%
143,078
+85.3%
0.00%
+300.0%
Q1 2023$2,954
-47.9%
77,224
-25.4%
0.00%
-66.7%
Q4 2022$5,674
-85.8%
103,552
+8616.5%
0.00%
Q3 2022$40,000
-64.9%
1,188
-90.2%
0.00%
Q2 2022$114,000
+6.5%
12,078
+58.7%
0.00%
Q1 2022$107,000
-92.9%
7,610
-89.3%
0.00%
Q4 2021$1,498,000
+375.6%
70,860
+403.7%
0.00%
Q3 2021$315,000
+131.6%
14,068
+156.9%
0.00%
Q2 2021$136,000
-63.1%
5,476
-57.1%
0.00%
Q1 2021$369,000
+141.2%
12,757
+114.8%
0.00%
Q4 2020$153,000
-39.3%
5,938
-27.3%
0.00%
Q3 2020$252,000
-41.9%
8,169
-53.0%
0.00%
Q2 2020$434,000
+635.6%
17,399
+525.4%
0.00%
Q1 2020$59,000
-47.3%
2,782
-44.6%
0.00%
Q4 2019$112,000
+83.6%
5,018
+88.9%
0.00%
Q3 2019$61,0002,6570.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders